TITLE

Neighborhood Socioeconomic Status, Depression, and Health Status in the Look AHEAD (Action for Health in Diabetes) Study

AUTHOR(S)
Gary-Webb, Tiffany L.; Baptiste-Roberts, Kesha; Pham, Luu; Wesche-Thobaben, Jacqueline; Patricio, Jennifer; Pi-Sunyer, F. Xavier; Brown, Arleen F.; Jones-Corneille, LaShanda; Brancati, Frederick L.
PUB. DATE
January 2011
SOURCE
BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p349
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Depression and diminished health status are common in adults with diabetes, but few studies have investigated associations with socio-economic environment. The objective of this manuscript was to evaluate the relationship between neighborhood-level SES and health status and depression. Methods: Individual-level data on 1010 participants at baseline in Look AHEAD (Action for Health in Diabetes), a trial of long-term weight loss among adults with type 2 diabetes, were linked to neighborhood-level SES (% living below poverty) from the 2000 US Census (tracts). Dependent variables included depression (Beck Inventory), and health status (Medical Outcomes Study (SF-36) scale). Multi-level regression models were used to account simultaneously for individual-level age, sex, race, education, personal yearly income and neighborhood-level SES. Results: Overall, the % living in poverty in the participants' neighborhoods varied, mean = 11% (range 0-67%). Compared to their counterparts in the lowest tertile of neighborhood poverty (least poverty), those in the highest tertile (most poverty) had significantly lower scores on the role-limitations(physical), role limitations(emotional), physical functioning, social functioning, mental health, and vitality sub-scales of the SF-36 scale. When evaluating SF-36 composite scores, those living in neighborhoods with more poverty had significantly lower scores on the physical health (β-coefficient [β] = -1.90 units, 95% CI: -3.40,-0.039), mental health (β = -2.92 units, -4.31,-1.53) and global health (β = -2.77 units, -4.21,-1.33) composite scores. Conclusion: In this selected group of weight loss trial participants, lower neighborhood SES was significantly associated with poorer health status. Whether these associations might influence response to the Look AHEAD weight loss intervention requires further investigation.
ACCESSION #
62664955

 

Related Articles

  • Depression and Diabetes.  // Diabetes Spectrum;Summer2004, Vol. 17 Issue 3, p167 

    Presents information on depression. Prevalence of depression in patients with diabetes; Symptoms of depression; Discussion on psychotherapy and drug therapy, the common treatments for depression.

  • Identifying Novel Approaches to Diabetes Prevention and Treatment: the Example of Depression. Lustman, Patrick J.; Clouse, Ray E. // Diabetes Spectrum;Summer2004, Vol. 17 Issue 3, p147 

    Reviews the evidence pointing toward depression as a medical risk factor for the development of type 2 diabetes. Advice for the management of depression in patients with diabetes; Estimated number of diabetes cases diagnosed annually in the U.S.; Risk facing people with diabetes; Discussion on...

  • Section III: Practical Considerations in the Management of Depression in Diabetes. Lustman, Patrick J.; Clouse, Ray E. // Diabetes Spectrum;Summer2004, Vol. 17 Issue 3, p160 

    Focuses on the association of depression with diabetes. Definition of depression; Diagnostic criteria for major depressive disorder; Benefits of depression management; Strategies for detecting depression in patients with diabetes.

  • THE SYMPTOMS OF DIABETES.  // Westchester County Business Journal;6/2/2008, Vol. 47 Issue 22, pS6 

    The article provides information related to diabetes. There are two common forms of diabetes, type I and type II diabetes. They are usually associated with poor diet and lack of exercise. Diabetes often goes undiagnosed because many of its symptoms seem so harmless. Its symptoms include frequent...

  • Cardiovascular highlights from non-cardiology journals  // Heart;Apr2001, Vol. 85 Issue 4, p373 

    Abstracts of several studies related to cardiovascular diseases are presented including the role of tissue plasminogen in the prevention of death, the importance of "glitazones" in the effective control of diabetes, and the role of losing weight and eating healthy foods in the control of blood...

  • Heading off diabetes.  // Patient Care;6/15/1994, Vol. 28 Issue 11, p162 

    Highlights the results of the study `Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes,' by SD Long and others from the journal `Diabetes Care.' Relationship between weight loss and impaired glucose tolerance in type II diabetes.

  • Evidence-based diabetes nutrition therapy recommendations are effective: the key is individualization. Franz, Marion J.; Boucher, Jackie L.; Evert, Alison B. // Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;2014, Vol. 7, p65 

    Current nutrition therapy recommendations for the prevention and treatment of diabetes are based on a systematic review of evidence and answer important nutrition care questions. First, is diabetes nutrition therapy effective? Clinical trials as well as systematic and Cochrane reviews report a...

  • Diabetic Gastroparesis Diagnosis and Management. Jing Ma; Rayner, Christopher K.; Jones, Karen L.; Horowitz, Michael // Drugs;2009, Vol. 69 Issue 8, p971 

    Gastric emptying is frequently abnormal in patients with long-standing type 1 and type 2 diabetes mellitus. Symptoms commonly associated with disordered gastric emptying include nausea, vomiting, bloating and epigastric pain, while patients are also at risk of malnutrition, weight loss, impaired...

  • INCRETIN ANALOGUE, LIRAGLUTIDE A NEWER TREATMENT APPROACH FOR TYPE-2 DIABETES MELLITUS. BINILA. T. BALAGOPAL; SIBY JOSEPH // International Journal of Pharma & Bio Sciences;Jul-Sep2013, Vol. 4 Issue 3, pP-890 

    Glucagon-like peptide 1 (GLP-1) receptor agonists, are one among the latest addition of medication included for the management of type 2 diabetes. Liraglutide, a novel long acting glucagon-like peptide analogue, is effective at improving indices of glycemic control. It has good tolerability and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics